BMJ, December 29, 2020. Volunteers in COVID-19 vaccine studies want the vaccine, not placebos, but stopping studies early could be dangerous.
Read More »Tag: covid-19 vaccine
Dr. Diana Zuckerman’s Testimony on Moderna’s COVID Vaccine Before the FDA Advisory Committee
December 17, 2020: We need at least 1 year of blinded, randomized, controlled data. We agree that FDA should delay access to vaccines by members of the placebo group unless they are in priority populations.
Read More »FDA Panel Reviewing Pfizer Vaccine Leaves Out Some Experts Who Raised Concerns
POGO, December 9, 2020. FDA’s coronavirus vaccine panel did not include experts who raised concerns about Pfizer’s data at a previous meeting.
Read More »Testimony of Dr. Diana Zuckerman of NCHR before the FDA Advisory Committee on Pfizer COVID Vaccine
December 10, 2020: We need longer-term data on the Pfizer COVID-19 vaccine to fully understand if benefits outweigh the risks for frail patients and all races/ethnicities, and for everyone else as well. It is essential that FDA ensure the continuation of the randomized controlled trial.
Read More »Will Covid-19 vaccines save lives? Current trials aren’t designed to tell us
October 21, 2020, BMJ. Current Covid-19 vaccine trials don’t give the public enough information on whether the vaccine is safe or will work for everyone.
Read More »